Nikoral Frukt (Nicotine)

Nicotine, the active ingredient in Nikoral Frukt, is a nicotine‑type drug presented as an oral formulation for oral use. It is employed to alleviate withdrawal symptoms and support adults who wish to stop using tobacco products, forming part of nicotine‑replacement therapy strategies for smoking cessation, and is regulated under European Union OTC guidelines. The product is designed for convenient self‑administration.

GNH USA supplies Nikoral Frukt as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Nikoral Frukt, a nicotine‑based oral product, is used in the management of nicotine dependence and related tobacco‑use disorders.

- Smoking cessation: helps adult smokers reduce cravings and withdraw from tobacco use. - Nicotine dependence: supports reduction of withdrawal symptoms during quitting attempts. - Tobacco use disorder: aids in the transition away from regular nicotine consumption.

Oral nicotine products can cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring after initial doses. - Mouth irritation: tingling or soreness in the oral cavity. - Headache: transient headache that usually resolves with continued use. - Dizziness: light‑headed sensation, particularly when standing quickly. - Insomnia: difficulty falling or staying asleep during early treatment.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Arrhythmia: irregular heart rhythm requiring medical attention. - Hypotension: marked drop in blood pressure leading to faintness. - Seizures: rare convulsive episodes, especially with excessive nicotine exposure.

Before using Nikoral Frukt, consider the following safety measures. - Assess cardiovascular status: evaluate history of heart disease before initiating therapy. - Avoid use in uncontrolled hypertension: monitor blood pressure regularly. - Do not combine with other nicotine replacement products: risk of excess nicotine. - Caution in patients with psychiatric disorders: nicotine may affect mood. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine may interact with several medicines; review the following categories.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive response. - CYP2A6 inhibitors: can increase nicotine plasma levels. - Other nicotine replacement therapies: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine may reduce their efficacy. - Antidepressants (SSRIs): monitor for altered mood effects. - Alcohol: concurrent use may increase cardiovascular strain.